VALTREAT-450 mg is an antiviral medication containing Valganciclovir 450 mg, indicated for the treatment and prevention of cytomegalovirus (CMV) infections, particularly in immunocompromised patients, such as post-organ transplant recipients.
Composition
Valganciclovir Hydrochloride – 450 mg
Uses
Treatment of cytomegalovirus (CMV) infection
Prevention of CMV disease in high-risk patients
Benefits
Effectively suppresses CMV replication
Reduces risk of CMV-related complications
Supports post-transplant care
Enhances overall immune protection in vulnerable patients
Disclaimer
This content is for informational purposes only and does not replace professional medical advice. Use only under the guidance of a registered healthcare professional.
